首页> 外文期刊>BMC Medical Research Methodology >How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies
【24h】

How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies

机译:在竞争性风险环境中无法衡量的混淆如何影响观察研究中的治疗效果估计

获取原文
           

摘要

Analysis of competing risks is commonly achieved through a cause specific or a subdistribution framework using Cox or Fine & Gray models, respectively. The estimation of treatment effects in observational data is prone to unmeasured confounding which causes bias. There has been limited research into such biases in a competing risks framework. We designed simulations to examine bias in the estimated treatment effect under Cox and Fine & Gray models with unmeasured confounding present. We varied the strength of the unmeasured confounding (i.e. the unmeasured variable’s effect on the probability of treatment and both outcome events) in different scenarios. In both the Cox and Fine & Gray models, correlation between the unmeasured confounder and the probability of treatment created biases in the same direction (upward/downward) as the effect of the unmeasured confounder on the event-of-interest. The association between correlation and bias is reversed if the unmeasured confounder affects the competing event. These effects are reversed for the bias on the treatment effect of the competing event and are amplified when there are uneven treatment arms. The effect of unmeasured confounding on an event-of-interest or a competing event should not be overlooked in observational studies as strong correlations can lead to bias in treatment effect estimates and therefore cause inaccurate results to lead to false conclusions. This is true for cause specific perspective, but moreso for a subdistribution perspective. This can have ramifications if real-world treatment decisions rely on conclusions from these biased results. Graphical visualisation to aid in understanding the systems involved and potential confounders/events leading to sensitivity analyses that assumes unmeasured confounders exists should be performed to assess the robustness of results.
机译:通常通过分别使用Cox或Fine&Gray模型的因果关系或子分布框架来分析竞争风险。在观察数据中对治疗效果的估计容易产生无法衡量的混淆,从而引起偏差。在竞争风险框架中,对此类偏见的研究很少。我们设计了模拟程序,以检查存在未测混杂因素的Cox和Fine&Gray模型下估计治疗效果的偏差。在不同情况下,我们改变了无法衡量的混杂因素(即,无法衡量的变量对治疗概率和两个结果事件的影响)的强度。在Cox模型和Fine&Gray模型中,未测量的混杂因素与治疗概率之间的相关性在与未测量的混杂因素对感兴趣事件的影响相同的方向(向上/向下)上产生了偏差。如果无法衡量的混杂因素影响竞争事件,则相关性和偏差之间的关联将被逆转。这些作用被逆转,以抵消比赛的治疗效果,当治疗臂不平衡时,这些作用会放大。在观察性研究中,不可忽视的混杂因素对关注事件或竞争事件的影响不应忽略,因为强相关性可能导致治疗效果估计值出现偏差,从而导致结果不准确,从而导致错误的结论。对于因果关系特定的角度而言,这是正确的,但对于子分布角度而言更是如此。如果现实世界中的治疗决策依赖于这些有偏见的结果得出的结论,这可能会产生后果。应当进行图形化可视化以帮助理解所涉及的系统和潜在的混杂因素/事件,从而进行敏感性分析(假设存在未测混杂因素),以评估结果的稳健性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号